about
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersGenome-wide association studies identify four ER negative-specific breast cancer risk lociCommon breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskLarge-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repairGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentNo clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersCOGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer.Common genetic variants and modification of penetrance of BRCA2-associated breast cancerThe contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.Exploring the link between MORF4L1 and risk of breast cancer.Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriersBreast-cancer risk in families with mutations in PALB2Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancerCommon variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarcheGenetic variation in mitotic regulatory pathway genes is associated with breast tumor gradeCommon non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association ConsortiumCommon breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants.Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649).MicroRNA related polymorphisms and breast cancer risk.Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2.Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Meta-analysis of mismatch repair polymorphisms within the cogent consortium for colorectal cancer susceptibility.Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases.Development of genomic resources for the tick Ixodes ricinus: isolation and characterization of single nucleotide polymorphisms.Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
P50
Q21144874-73CFA73E-59F1-4394-994F-26FB5734D422Q24622610-431E3D8E-637B-46AD-B823-E6218B5BF48BQ24655824-757E9642-1655-44E0-B6A3-70013C6376C2Q27008356-F2D57C50-3561-456D-88D8-0DAC3E8AFDC7Q28267893-D7DBF9E6-0A1C-4467-9CAB-EBB3105F7946Q28388497-BBEEA7E5-579A-407F-9042-FFC8AE0B5601Q28584533-462D2786-4B0E-436E-A680-4DD8586CB2DCQ29416989-21E7E7E4-9090-4B28-90A0-06E6A2D93C55Q30000080-3D2E0B5F-DA04-4DF5-9843-D2F7902327EAQ30374367-5124EE58-7065-4A30-B1FC-352C12226193Q31043651-3FB21F24-DD56-4FA6-B425-69893F824841Q31049299-542B1106-29A1-476F-8482-6642DA2460C4Q31082788-505D08F1-8326-44C8-ACA1-01F258E5C00AQ33614244-649CE8A2-1037-41F5-9F4E-34E3FB8AA3DFQ33630773-E8BA1EF3-C579-44E7-B7AE-909FCA4883F3Q33742096-C9DDC02F-99E8-47DC-91D4-704C14EA2773Q33784408-B3F5D1CF-BC63-49FA-8C2A-6D3A8B915505Q33863235-5CAD6EA3-E65C-487E-A636-171C5178A190Q34081324-6C2AF24A-15E9-424F-83FE-A2899A73975CQ34115636-37525898-825C-4FEC-9874-C6497A448EBAQ34148873-BA740827-3204-4D9C-B273-D34641C7AF8CQ34181322-483C8BFB-FA7F-4BFD-897A-7E7443507A0CQ34213403-EC1FE01C-98B5-454D-8BE0-C213F469D3C0Q34289136-B346ACE5-C7E6-44D0-8460-5719C02138DDQ34378972-BB9E381E-6C0C-4D41-BA92-4220311D53A8Q34379032-F6EDD36D-97F7-4F44-9EC5-3E720F5EBD4DQ34394665-53E6B321-576D-4807-A459-67D3A5C4E4BBQ34433744-1385767D-3ACE-4E09-A952-D4BC82D7BBACQ34483516-485A5D93-FD7F-441F-9A9C-1AEE99C7F530Q34497352-0BB03DD5-31C5-413A-9101-16732D31D8AAQ34586198-AA1C28BE-1A64-49FC-A421-2EB2692F1DC9Q34806825-07F7AAEB-9340-48FD-B4C8-36EA3F2B6DBBQ34903062-A183B04B-2D12-4C0B-A5F3-5CA595946BF6Q34963894-966F6EB6-AAEA-4EBF-9FB1-6E58657591A9Q34988292-76B96BA3-E068-413F-9051-660F3A5C14BAQ35009015-63B75FAD-DAAE-4EAE-9609-E25E949DD4BFQ35015869-C42B18AF-BEDF-4D58-ABAD-9A6D5B9E26B7Q35022825-2E21814D-F3A9-4ABC-959C-EE5F604BEEB3Q35064451-D582E9C8-ADAC-415D-9CE4-6D15E7945642Q35089479-C14D2FD3-0C9B-48EE-AE24-AC2AC98878FE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paolo Peterlongo
@ast
Paolo Peterlongo
@en
Paolo Peterlongo
@es
Paolo Peterlongo
@nl
Paolo Peterlongo
@pt
Paolo Peterlongo
@sl
type
label
Paolo Peterlongo
@ast
Paolo Peterlongo
@en
Paolo Peterlongo
@es
Paolo Peterlongo
@nl
Paolo Peterlongo
@pt
Paolo Peterlongo
@sl
altLabel
Peterlongo P
@en
prefLabel
Paolo Peterlongo
@ast
Paolo Peterlongo
@en
Paolo Peterlongo
@es
Paolo Peterlongo
@nl
Paolo Peterlongo
@pt
Paolo Peterlongo
@sl
P106
P21
P2798
P31
P496
0000-0001-6951-6855